-
Loading metrics
Open Access
Peer-reviewed
Research Article
Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
-
Fredrik Nyberg ,
Contributed equally to this work with: Fredrik Nyberg, Atsushi Ogiwara, Chris G. Harbron
* E-mail: Fredrik.Nyberg@astrazeneca.com
Affiliations Global Epidemiology, AstraZeneca R&D, Mölndal, Sweden, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
⨯ -
Atsushi Ogiwara ,
Contributed equally to this work with: Fredrik Nyberg, Atsushi Ogiwara, Chris G. Harbron
Affiliations Research and Development Division, Medical ProteoScope Company, Tokyo, Japan, Clinical Proteome Center, Tokyo Medical University, Tokyo, Japan
⨯ -
Chris G. Harbron ,
Contributed equally to this work with: Fredrik Nyberg, Atsushi Ogiwara, Chris G. Harbron
Affiliation Discovery Statistics, AstraZeneca R&D, Macclesfield, United Kingdom
⨯ -
Takao Kawakami,
Affiliations Research and Development Division, Medical ProteoScope Company, Tokyo, Japan, Clinical Proteome Center, Tokyo Medical University, Tokyo, Japan
⨯ -
Keiko Nagasaka,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Sachiko Takami,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Kazuya Wada,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Hsiao-Kun Tu,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Makiko Otsuji,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Yutaka Kyono,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Tae Dobashi,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Yasuhiko Komatsu,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Makoto Kihara,
Affiliation Research and Development Division, Medical ProteoScope Company, Tokyo, Japan
⨯ -
Shingo Akimoto,
Affiliations Research and Development Division, Medical ProteoScope Company, Tokyo, Japan, Clinical Proteome Center, Tokyo Medical University, Tokyo, Japan
⨯ -
Ian S. Peers,
Affiliation Discovery Statistics, AstraZeneca R&D, Macclesfield, United Kingdom
⨯ -
Marie C. South,
Affiliation Discovery Statistics, AstraZeneca R&D, Macclesfield, United Kingdom
⨯ -
Tim Higenbottam,
Current address: Chiesi Farmaceutici, Parma, Italy
Affiliation AstraZeneca in Respiratory Biological Sciences, AstraZeneca R&D, Lund, Sweden
⨯ -
Masahiro Fukuoka,
Affiliation Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan
⨯ -
Koichiro Nakata,
Affiliation Nakata Clinic, Tokyo, Japan
⨯ -
Yuichiro Ohe,
Affiliation Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan
⨯ -
Shoji Kudoh,
Affiliations Japan Anti-Tuberculosis Association Fukujuji Hospital, Tokyo, Japan, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
⨯ -
Ib Groth Clausen,
Affiliation Respiratory Biological Sciences, AstraZeneca R&D, Lund, Sweden
⨯ -
Toshihide Nishimura,
Affiliations Research and Development Division, Medical ProteoScope Company, Tokyo, Japan, Clinical Proteome Center, Tokyo Medical University, Tokyo, Japan
⨯ -
György Marko-Varga,
Current address: Division of Clinical Protein Science and Imaging, Biomedical Center, Department of Measurement Technology and Industrial Electrical Engineering, Lund University, Lund, Sweden; Department of Surgery, Tokyo Medical University, Tokyo, Japan
Affiliations AstraZeneca in Respiratory Biological Sciences, AstraZeneca R&D, Lund, Sweden, Department of Surgery, Tokyo Medical University, Tokyo, Japan
⨯ - [ ... ],
-
Harubumi Kato
Affiliations Department of Surgery, Tokyo Medical University, Tokyo, Japan, Niizashiki Central General Hospital, Saitama, Japan
⨯ - [ view all ]
- [ view less ]
Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
- Fredrik Nyberg,
- Atsushi Ogiwara,
- Chris G. Harbron,
- Takao Kawakami,
- Keiko Nagasaka,
- Sachiko Takami,
- Kazuya Wada,
- Hsiao-Kun Tu,
- Makiko Otsuji,
- Yutaka Kyono
- Published: July 20, 2011
- https://doi.org/10.1371/journal.pone.0022062